Tranexamic acid and Cymbalta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tranexamic acid (tranexamic acid) and Cymbalta (duloxetine hydrochloride). Common drug interactions include arthralgia among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Tranexamic acid and Cymbalta. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Tranexamic acid?

Tranexamic acid has active ingredients of tranexamic acid. It is often used in heavy or prolong menstrual bleeding. eHealthMe is studying from 8,687 Tranexamic acid users. Check the latest studies of Tranexamic acid.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,973 Cymbalta users. Check the latest studies of Cymbalta.

On Jul, 06, 2026

51 people who take Tranexamic acid and Cymbalta together, and have interactions are studied.

Tranexamic acid and Cymbalta drug interactions.

What are the common drug interactions of Tranexamic Acid and Cymbalta, by gender? *:

female:

Arthralgia (joint pain)
Asthma
Blood cholesterol increased
Blood pressure increased
Decreased appetite
Cough
Urinary tract infection
Dizziness
Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)

male:

Abdominal pain
Retinal haemorrhage (bleeding from retina)
Lung disorder (lung disease)
Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Nephrogenic anaemia (anaemia due to kidney disease)
Pruritus (severe itching of the skin)
Renal failure (kidney dysfunction)
Rib fracture
Road traffic accident

What are the common drug interactions of Tranexamic Acid and Cymbalta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Angioedema (rapid swelling of the dermis)
Aphthous ulcer (mouth ulcer)
Back pain
Bone pain
Headache (pain in head)
Kidney infection
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Oral discomfort (pain or irritation in mouth)
Pain

30-39:

Anaemia (lack of blood)
Gastroenteritis (inflammation of stomach and intestine)
Hordeolum (small collection of pus (abscess) on the eyelid)
Insomnia (sleeplessness)
Muscle spasms (muscle contraction)
Upper respiratory tract inflammation
Cholinergic syndrome (symptoms of increased cholinergic stimulation)
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Vomiting

40-49:

Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
Intentional self-injury
Decreased appetite
Hangover
Localised infection (infection at the single location)
Cough
Pyrexia (fever)
Urticaria (rash of round, red welts on the skin that itch intensely)
Aphonia (inability to produce voice)
Arthritis (form of joint disorder that involves inflammation of one or more joints)

50-59:

Urinary tract infection
Nausea (feeling of having an urge to vomit)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Burning sensation
Dizziness
Hypoaesthesia (reduced sense of touch or sensation)
Ligament sprain (ligament stretched)
Lymphocyte count decreased
Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)

60+:

Cerebral infarction (less blood supply to brain resulting tissue damage)
Abdominal pain
Renal failure (kidney dysfunction)
Tongue haemorrhage (bleeding from tongue)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Retinal haemorrhage (bleeding from retina)
Sepsis (a severe blood infection that can lead to organ failure and death)
Hypophagia (reduced food intake)
Chronic kidney disease

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 17.65%
Pain: 8 people, 15.69%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 13.73%
Diabetes: 6 people, 11.76%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 9.80%
Migraine (headache): 5 people, 9.80%
Insomnia (sleeplessness): 5 people, 9.80%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 7.84%
Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 4 people, 7.84%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 7.84%

* Approximation only. Some reports may have incomplete information.

Do you take Tranexamic acid and Cymbalta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously